+Compare
HZNP
Stock ticker:
NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
22.05B

HZNP Price Prediction, Horizon Therapeutics Public Limited AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

GET INTRADAY SIGNALS
HZNP Trading results, last 6 months
AI Robots NameP/L
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EST Dec 09, 2022

HZNP's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for HZNP turned positive on November 30, 2022. Looking at past instances where HZNP's MACD turned positive, the stock continued to rise in 38 of 45 cases over the following month. The odds of a continued upward trend are 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 22, 2022. You may want to consider a long position or call options on HZNP as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HZNP advanced for three days, in of 302 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 246 cases where HZNP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HZNP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HZNP broke above its upper Bollinger Band on November 30, 2022. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 59, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HZNP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.380) is normal, around the industry mean (5.353). P/E Ratio (40.000) is within average values for comparable stocks, (33.394). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.293). HZNP's Dividend Yield (0.000) is considerably lower than the industry average of (0.026). P/S Ratio (6.207) is also within normal values, averaging (4.162).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

HZNP is expected to report earnings to fall 13.60% to $1.08 per share on March 01

Horizon Therapeutics Public Limited HZNP Stock Earnings Reports
Q4'22
Est.
$1.08
Q3'22
Beat
by $0.19
Q2'22
Missed
by $0.26
Q1'22
Beat
by $0.20
Q4'21
Beat
by $0.06
The last earnings report on November 02 showed earnings per share of $1.25, beating the estimate of $1.06. With 2.23M shares outstanding, the current market capitalization sits at 22.05B.
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Johnson & Johnson (NYSE:JNJ), Eli Lilly & Co (NYSE:LLY), Pfizer (NYSE:PFE), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), AstraZeneca PLC (NASDAQ:AZN), Bristol-Myers Squibb Co (NYSE:BMY), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 81.9B. The market cap for tickers in the group ranges from 226K to 459.47B. JNJ holds the highest valuation in this group at 459.47B. The lowest valued company is NEWG at 226K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was -1%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 1%. CHJTF experienced the highest price growth at 16%, while CRXTQ experienced the biggest fall at -36%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was -60%. For the same stocks of the Industry, the average monthly volume growth was -65% and the average quarterly volume growth was -69%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 24
P/E Growth Rating: 45
Price Growth Rating: 46
SMR Rating: 44
Profit Risk Rating: 58
Seasonality Score: 23 (-100 ... +100)
AI
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
70 St. Stephen’s Green
Phone
+353 17722100
Employees
1890
Web
https://www.horizontherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRZE26.620.09
+0.34%
Braze
CRMD3.78N/A
N/A
CorMedix
CATC86.38-1.46
-1.66%
Cambridge Bancorp
MGM36.35-0.65
-1.77%
MGM Resorts International
SDIG0.51-0.02
-4.27%
Stronghold Digital Mining

HZNP and

Correlation & Price change

A.I.dvisor indicates that over the last year, HZNP has been loosely correlated with LLY. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if HZNP jumps, then LLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HZNP
1D Price
Change %
HZNP100%
+0.39%
LLY - HZNP
35%
Loosely correlated
-2.90%
AZN - HZNP
33%
Poorly correlated
+0.55%
NVS - HZNP
32%
Poorly correlated
-0.70%
BIIB - HZNP
30%
Poorly correlated
-1.29%
BMY - HZNP
24%
Poorly correlated
-1.33%
More